Form 4: BioAtla CEO Jay M. Short Reports Tax-Related Share Withholding
SEC Form 4 Filing
BioAtla's CEO, Jay M. Short, reports the withholding of shares to cover income tax obligations related to the vesting of restricted stock units.
Summary
- On February 16, 2025, Jay M. Short, the CEO of BioAtla, Inc., reported a transaction involving the withholding of 30,911 shares of common stock by the issuer to cover income tax obligations.
- The shares were withheld at a price of $0.46 per share.
- Following the transaction, Short directly owns 1,825,372 shares of BioAtla common stock.
- Short also has indirect ownership through his spouse (793,547 shares), the Carolyn Short 2020 Irrevocable Gift Trust (258,727 shares), the Jay Short 2020 Irrevocable Gift Trust (258,727 shares), Capia IP, LLC (302,324 shares), and Himalaya Parent LLC (50 shares).
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a routine tax-related transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax withholding process related to vested equity compensation.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a standard tax withholding procedure.
Key Dates
| Date | Description |
|---|---|
| 02/16/2025 | Date of the transaction (share withholding). |
| 02/24/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Insider Trading, Jay M. Short, BioAtla, BCAB, Tax Withholding, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.